Boston Scientific (NYSE:BSX) Price Target Raised to $117.00 at Truist Financial
Boston Scientific (NYSE:BSX – Free Report) had its price target raised by Truist Financial from $113.00 to $117.00 in a research report released on Thursday, MarketBeat Ratings reports. They currently have a buy rating on the medical equipment provider’s stock. Other research analysts have also issued reports about the stock. Argus set a $130.00 target […]
